select trial semaglutide cardiovascular outcomes without diabetes 2023 of and tirzepatide for patients with type 2 in clinical practice #VisualAbstract: Semaglutide and Cardiovascular Outcomes

Focusing on clinically guided lifestyle and nutrition programs, supplemented when appropriate with proven medical therapies, promotes long-term health while keeping spending in check

Design of hybrid multimodal poly(lactic-co-glycolic acid) polymer nanoparticles for neutrophil labeling, imaging and tracking

IVs work faster than pills

My colleagues who are in the enhancement longevity world, they look at the drug protocol for Enhanced for the study, and they say, Oh, my God, how boring. Its true, he says, but this is the first study [on athletes], and theres so much headwind for this type of studies that it wouldve been too far-fetched to go full in. That is to say there will be more, and theyre simply testing the waters

Looking ahead, the researchers say more studies are needed to explore whether slowing dose increases could reduce this risk, whether the pain goes away with continued treatment, and whether allodynia could point to other underlying health issues